Karyopharm Therapeutics Inc. (KPTI) (CIK 0001503802) (KPTI)
Activity window: Oct. 25, 2025 to Oct. 24, 2026
Export this company’s current score, component values, matched signals, and scoring date as a one-row CSV snapshot.
The total combines correspondence volume, AI sentiment, matched keywords and signals, and a weighted 8-K adjustment, capped at 10.0. This is the 365-day v1 snapshot. Computed: Oct. 24, 2026. Latest filing activity: May. 12, 2026. These dates describe different events.
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| May. 12, 2026 | CORRESP | Neutral/Informational | High | Karyopharm Therapeutics Inc. has submitted a request for the acceleration of the effective date of its Registration Statement on Form S-3, which was filed on May 4, 2026. The comp… | Read Filing EDGAR |
| May. 12, 2026 | CORRESP | Neutral/Informational | Moderate | Karyopharm Therapeutics Inc. has submitted a request for the acceleration of the effective date of its Registration Statement on Form S-3, which was filed on May 4, 2026. The comp… | Read Filing EDGAR |
| May. 7, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Karyopharm Therapeutics Inc. that they will not be reviewing the company's registration statement filed on May 4, 2026. The letter emphasizes the compa… | Read Filing EDGAR |
| May. 7, 2026 | UPLOAD | Neutral/Informational | Low | The SEC correspondence dated May 7, 2026, informs Karyopharm Therapeutics Inc. that their registration statement on Form S-3, filed on May 4, 2026, will not be reviewed by the SEC… | Read Filing EDGAR |